Kelsey Shasteen
Adult Health · Murfreesboro, TNNPI 1730742479
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 212 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Boston Scientific at 47.5% of the total. Reporting peaked in 2023 at $1,560 and has fallen 71.8% since, to $440 in 2025.
Across 212 payments — averaging $21.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- AbbVie$521
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$464
- Collegium Pharmaceutical, Inc.$306
- Vertos Medical, Inc.$110
- Stimwave Technologies Incorporated$108
- plus $827 from 16 others
What the payments were for
- Food & beverage$4,452100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 98 | $2,116 |
| AbbVie(2 entities) | 23 | $521 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 31 | $464 |
| Collegium Pharmaceutical, Inc. | 18 | $306 |
| Vertos Medical, Inc. | 2 | $110 |
| Stimwave Technologies Incorporated | 1 | $108 |
| Pfizer | 7 | $107 |
| Nevro Corp. | 6 | $98 |
| Impel Pharmaceuticals Inc. | 5 | $90 |
| Medtronic | 2 | $89 |
| SPR Therapeutics, Inc | 1 | $80 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $78 |
| Lundbeck LLC | 3 | $60 |
| Curonix LLC | 3 | $50 |
| Vertex | 1 | $27 |
| Amgen | 1 | $26 |
| Nalu Medical, Inc. | 1 | $25 |
| Impel Pharmaceuticals LLC | 1 | $22 |
| Protega Pharmaceutials Inc | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Scilex Pharmaceuticals Inc. | 1 | $19 |
| Painteq LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WaveWriter Alpha Prime 16$897
- BOTOX$109
- StimQ Receiver Stimulator Kit Channel A US w Receiver$108
- StimQ Freedom-4A Receiver Kit Channel A US w/ Receiver$108
- StimQ Freedom 8A Receiver Kit Channel A US w Receiver$108
- Freedom 4A Receiver Kit Channel A US w Receiver$108
- Freedom 8A Receiver Kit Channel A US w Receiver$108
How this compares
$4,452 in reported general payments places this provider in the 85th percentile of 352 adult health providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RelistorMethylnaltrexone Bromide | 21 | $57,108 |
| Xtampza ErOxycodone Myristate | 91 | $51,021 |
| BelbucaBuprenorphine Hcl | 61 | $43,561 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,030 | $25,302 |
| Nurtec OdtRimegepant Sulfate | 24 | $23,265 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 798 | $19,809 |
| MovantikNaloxegol Oxalate | 36 | $14,441 |
| Buprenorphine | 58 | $14,086 |
| QuliptaAtogepant | 12 | $12,431 |
| Ajovy SyringeFremanezumab-Vfrm | 12 | $8,364 |
| Gabapentin | 616 | $8,045 |
| LinzessLinaclotide | 15 | $7,629 |
| Oxycodone Hcl | 299 | $6,541 |
| Cyclobenzaprine Hcl ErCyclobenzaprine Hcl | 11 | $5,376 |
| Pregabalin | 331 | $5,121 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca | $306 | $94,581152 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $464 | $57,10821 claims |
| PfizerNurtec Odt | $107 | $23,26524 claims |
| AbbVieQulipta, Linzess | $521 | $20,06127 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 352 adult health providers in Tennessee.
Other adult health in Murfreesboro
- Linda BonifieldMurfreesboro$10K
- Megan ChildersMurfreesboro$10K
- Gillian ChoateMurfreesboro$8K
- Sarah TrentMurfreesboro$6K
- Brenda BaxterNashville$246K
- Artangela HenryMemphis$74K
- Luisa LealNashville$49K
- Robbie LeinartKnoxville$48K
- Terrye MastinMemphis$34K
- Marshe TurnerMemphis$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.